Windlas Biotech approved a Rs 47 crore share buyback at Rs 1,000 per share via the tender route, with April 24 set as the record date. The move covers 2.23% equity and excludes promoters. Shares rose 2% following the announcement, reflecting positive investor sentiment toward the capital return plan.